Reduced tumor burden and disease progression were observed in the mice treated with CD147-CAR-NK-92MI cells (Fig. 4e–h), indicating the effectiveness of CD147-CAR-NK-92MI cells in suppressing liver cancer progression in our PDX mouse model. This evidence concerns the gene BSG and neoplasm.